This gives us both state-of-the-art diagnostic capabilities for prostate cancer and gives us state-of-the art treatments for ...

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

Breast cancer is the most prevalent malignancy among women worldwide. Phototheranostics—an approach that uses light both to ...

Researchers convert caffeine molecules into carbon quantum dots to enhance their ability to target and inhibit cancer cell ...

Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well ...

Illuccix, after radiolabelling with gallium-68, is indicated in Greece for the detection of prostate-specific membrane ...

Monopar Therapeutics Inc. (“Monopar,” the “Company,” “us” and “our”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet ...

The payments were previously withheld because of people paying out of pocket for MRIs and ultrasounds at private clinics in ...

Psilocybin induces consistent and sustained changes in brain network connectivity, particularly between the hippocampus and ...

As part of the SNMMI conference, Dr. Celine Wilke, ITM's Chief Medical Officer will participate in the "Entrepreneur's Panel: ...

Jerry Katzman, MD, CEO of RetinalGenix Technologies, expressed his enthusiasm: ...